# Peter J. Allen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-j-allen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 53,839 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 107 |
| i10-index | 334 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5108078524 |
| Works | 558 |

## Researcher papers

- [Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies](https://scholariq.org/papers/detection-of-circulating-tumor-dna-in-early-and-late-stage-human-malignancies/)
- [Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013](https://scholariq.org/papers/global-regional-and-national-comparative-risk-assessment-of-79-behavioural-2/)
- [FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis](https://scholariq.org/papers/folfirinox-for-locally-advanced-pancreatic-cancer-a-systematic-review-and/)
- [Recurrent <i>GNAS</i> Mutations Define an Unexpected Pathway for Pancreatic Cyst Development](https://scholariq.org/papers/recurrent-i-gnas-i-mutations-define-an-unexpected-pathway-for-pancreatic-cyst/)
- [Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers](https://scholariq.org/papers/combined-circulating-tumor-dna-and-protein-biomarker-based-liquid-biopsy-for-the/)
- [Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma](https://scholariq.org/papers/multi-institutional-validation-study-of-the-american-joint-commission-on-cancer/)
- [A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts](https://scholariq.org/papers/a-combination-of-molecular-markers-and-clinical-features-improve-the/)
- [Benchmarks in Pancreatic Surgery](https://scholariq.org/papers/benchmarks-in-pancreatic-surgery/)
- [Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract](https://scholariq.org/papers/pathologic-evaluation-and-reporting-of-intraductal-papillary-mucinous-neoplasms/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.